ARDELYX, INC.

Lobbying for ARDELYX, INC.

Filing 2nd Quarter - Amendment

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $500,000.00 expenses · posted Jul 16, 2026

Lobbying activity 1

Health Issues

Access to innovative medications for people with kidney failure; reimbursement; drug pricing; most favored nation drug pricing; Medicare kidney care access and payment issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.